Tuesday, February 9, 2021

Novel blood cancer drug developed by Alembic Pharma#39;s associate Rhizen gets US approval

Novel blood cancer drug developed by Alembic Pharma#39;s associate Rhizen gets US approval Umbralisib has peak market size potential to reach $1 billion - $1.5 billion

from Moneycontrol Business News https://ift.tt/3rDCxWO

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...